Vertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.

But it's logical to ask: What's Vertex's long-term story? Where will the company be in 10 years, for example? Let's find out. Image source: Getty Images. First, a bit of background on Vertex's CF ...

Vertex Pharmaceuticals has discontinued the development of VX-264, a type 1 diabetes (T1D) cell therapy delivered via an implantable device, after clinical trial data showed the treatment did not ...

Most of the focus in generative AI has been on text-based interfaces used to generate text, images, and more ... HD text-to-speech models — to its Vertex AI development platform starting ...

A world with AI powering our services is already here, and Ireland has a strong chance of becoming a global leader ...

Online creative marketplace Envato has launched VideoGen, a new feature that enables creative professionals to turn text or ...

The Power Of Love scored Huey Lewis and the News their first number one and an Oscar nod but as Hayes remembers it he just ...

Microsoft’s approach offers a compelling opportunity to secure AI, leverage AI-driven security tools and establish a ...

Like many tech stocks, Alphabet's (NASDAQ: GOOGL) (NASDAQ: GOOG) stock pulled back in recent months. Investors still question ...

Explore Google's new Gemini 2.5 Pro's advanced AI features, from coding to ethical reasoning, and its transformative impact ...

“Little House on the Prairie” star Melissa Gilbert shared an emotional tribute to her series co-star Jack Lilley, who died at ...